HK85196A - Pharmaceutical formulations

22 members in 14 offices

This recordMember, by publication datePriority claim4 more offices are in the list below

Priority claims
Document	Office	Kind	Date
8918809	United Kingdom	A	1989-08-17
9001299	United Kingdom	W	1990-08-17
43050095	United States of America	A	1995-04-28

Family members, oldest first
Document	Office	Kind
GB8918809D0	United Kingdom	D0	1989-09-27
CA2063791A1	Canada	A1	1991-02-18
WO9102520A1	World Intellectual Property Organization (WIPO)	A1	1991-03-07
AU6161990A	Australia	A	1991-04-03
FI920646A7	Finland	A7	1992-02-14
NO920604D0	Norway	D0	1992-02-14
NO920604L	Norway	L	1992-02-14
EP0487575A1	European Patent Office (EPO)	A1	1992-06-03
JPH04507418A	Japan	A	1992-12-24
AU633959B2	Australia	B2	1993-02-11
EP0487575B1	European Patent Office (EPO)	B1	1994-11-02
AT113471T	Austria	T	1994-11-15
ATE113471T1	Austria	T1	1994-11-15
DK0487575T3	Denmark	T3	1994-11-28
DE69013923D1	Germany	D1	1994-12-08
ES2062543T3	Spain	T3	1994-12-16
DE69013923T2	Germany	T2	1995-03-16
HK85196AThis record	Hong Kong, China	A	1996-05-24
US5532002A	United States of America	A	1996-07-02
NO302333B1	Norway	B1	1998-02-23
US5738871A	United States of America	A	1998-04-14
CA2063791C	Canada	C	2000-12-19

1 legal event, as the office reported them to INPADOC

Legal events, newest first
	Event	Code
2004-12-15	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)CeasedPC	PC

CPC, 3: A61K9/4858
A23V2002/00
A23L33/15
Filled: the office’s first classification
IPC, 8: A23L33 15
A61K9 48
A61K31 015
A61K31 047
A61K31 12
A61K31 23
A61K31 355
A61K31 59

Pharmaceutical formulations